Respiratory Trials·org

Ventilation & weaning · Non-invasive ventilation in hypoxaemic failure

Ferrer 2003 randomised trial

Noninvasive ventilation in severe hypoxemic respiratory failure

Ferrer 2003 trial design and results
Design Randomised clinical trial in three hospitals
Treatment Non-invasive ventilation
Control High-concentration oxygen therapy
Population 105 patients with severe acute hypoxaemic respiratory failure, excluding hypercapnia
Inclusion criteria PaO2 60 mmHg or less, or saturation 90% or less, persisting on Venturi oxygen at 50%, without hypercapnia.
Follow-up 90 days
Primary endpoint Intubation rate
Result Intubation occurred in 13 of 51 (25%) with non-invasive ventilation versus 28 of 54 (52%) with oxygen (p=0.010). Septic shock occurred in 12% versus 31% (p=0.028) and ICU mortality was 18% versus 39% (p=0.028), with better cumulative 90-day survival (p=0.025). On multivariate analysis non-invasive ventilation was independently associated with lower intubation risk (odds ratio 0.20, p=0.003) and 90-day mortality (odds ratio 0.39, p=0.017).
Secondary endpoints Septic shock, ICU mortality, 90-day survival, gas exchange

The use of noninvasive ventilation prevented intubation, reduced the incidence of septic shock, and improved survival in these patients compared with high-concentration oxygen therapy.

The trial authors, in the published abstract

How it has aged

A striking early positive result that later trials struggled to reproduce — FLORALI found non-invasive ventilation the worst of its three arms in a similar population. Small, single-country and pre-dating high-flow oxygen entirely, it is best read as the origin of a question rather than its answer.

Publications

Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial

Ferrer M, Esquinas A, Leon M, et al. Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. Am J Respir Crit Care Med 2003 Dec 15;168(12):1438-44.

  • Intubation reduced from 52% to 25%
  • ICU mortality reduced from 39% to 18%
  • Lower incidence of septic shock